Keratoconus is an eye disorder characterized by progressive thinning and changes in the shape of the cornea.
Keratoconus Epidemiology Segmentation in the 7MM from 2017 to 2030
- Total Diagnosed Prevalent Population of Keratoconus
- Severity-specific Distribution of Keratoconus
- Age-specific Distribution of Keratoconus
Keratoconus Epidemiology Insights
- The total diagnosed prevalent population of Keratoconus in 7MM in 2017 was 1,602,427
-
Keratoconus affects both males and females equally
- The prevalent cases of Keratoconus in the United States in 2017
- Mild Keratoconus- 121,010 cases
- Moderate Keratoconus – 313,527 cases
- Severe Keratoconus- 115,510 cases
- The diagnosed prevalent cases of Keratoconus in 2017
- the United States – 550,047
- Germany -218,772
- Italy – 171,676
- Spain – 105,463
- Japan- 240,591
Scope of the Report
- The Keratoconus report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
- The Keratoconus Epidemiology Report and Model provide an overview of the risk factors and global trends of Keratoconus in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
- The report provides insight about the historical and forecasted patient pool of Keratoconus in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
- The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
- The report assesses the disease risk and burden and highlights the unmet needs of Keratoconus
- The report provides the segmentation of the Keratoconus epidemiology
Request for sample pages @ Keratoconus epidemiology report
Table of contents
1. Key Insights
2. Executive Summary of Keratoconus
3. Keratoconus: Disease Background and Overview
3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis
4. Patient Journey
5. Epidemiology and Patient Population
5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
5.3.1. Keratoconus Epidemiology Scenario in the 7MM (2017- 2030)
5.4. United States Epidemiology
5.4.1. Keratoconus Epidemiology Scenario in the United States (2017- 2030)
5.5. EU-5 Country-wise Epidemiology
5.5.1. Germany Epidemiology
5.5.1.1. Keratoconus Epidemiology Scenario in Germany (2017- 2030)
5.5.2. France Epidemiology
5.5.2.1. Keratoconus Epidemiology Scenario in France (2017- 2030)
5.5.3. Italy Epidemiology
5.5.3.1. Keratoconus Epidemiology Scenario in Italy (2017- 2030)
5.5.4. Spain Epidemiology
5.5.4.1. Keratoconus Epidemiology Scenario in Spain (2017- 2030)
5.5.5. United Kingdom Epidemiology
5.5.5.1. Keratoconus Epidemiology Scenario in the United Kingdom (2017-2030)
5.6. Japan Epidemiology
5.6.1. Keratoconus Epidemiology Scenario in Japan (2017- 2030)
6. Treatment Algorithm, Current Treatment, and Medical Practices
6.1. Keratoconus Treatment and Management
6.2. Keratoconus Treatment Algorithm
7. KOL Views
8. Unmet Needs
9. Appendix
9.1. Bibliography
9.2. Report Methodology
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
Media Contact
Company Name: DelveInsight
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/